2nd IAS Conference on HIV Pathogenesis and Treatment, 13-16 July 2003, Paris
This biannual conference alternates with the the International AIDS (World AIDS) conferences.
Location is also planned to alternate between a developed country and one where access to treatment is still not widely available – the first meeting was held in Buenos Aires in 2001 – in order to maintain a balance between new science and the importance of access issues.
The second meeting – this year in Paris – attracted 6,000 delegates from 120 countries. One thousand eight hundred abstracts were received, 180 of which were selected for oral presentations and more than 900 for poster presentations. None of them however were available online as we went to press – although webcasts and other resources for all conference plenaries and selected other sessions are provided by the Kaiser Family Foundation online; they do not include the facility to see the slides being referred to in the lectures:
- Challenges and lessons learned in implementing antiretroviral therapy in the developing world
- Host/virus mechanisms in the molecular pathogenesis of HIV
- New antiretroviral drugs and therapeutic strategies
- HIV vaccine research: the state of the science
- HIV entry: insights into viral tropism, pathogenesis, and antiviral therapy
- Mechanisms and management of metabolic complications associated with highly active antiretroviral therapy
- HIV drug resistance
- The scaling-up of antiretroviral therapy in developing countries
- Mother-to-child HIV transmission
- 20 Years of HIV Science
- From Science to Action: Challenges in Managing AIDS
Reports in this issue of HTB are:
- First results from ESPRIT study: CD4 response to IL-2 is associated with higher nadir and baseline CD4 and younger age
Further reports will also be included in the next issue.
All references are from the programme and abstracts of The 2nd IAS conference on HIV pathogenesis and treatment, Paris, France 13-16 July 2003 unless otherwise stated.